JUMP REPORT
DOCUSIGN (DOCU)
EARNINGS RELEASE - SEPTEMBER 3 (AMC)
EARNINGS EXPECTATIONS:
THIS QTR: EPS: .08/share REV: 318.6/M
___________________________________________________________
NEXT QTR: EPS: .12/share REV: 335.1/M
____________________________________________________________
FULL YR: EPS: .48/share REV: 1,320/M
____________________________________________________________
LAST QTR: EPS: .10/share ACTUAL: .12/share (BEAT)
____________________________________________________________
BEAT/MISS RECORD: 50% OF THE TIME THEY BEAT ESTIMATES
PRIOR ‘JUMP ZONE’ MOVES (LAST 3 QTRS %) -6.28, 15.81, 9.13
EXPECTED JUMP MOVE THIS QUARTER: 10%
——–
*** With market volatility at extremes there is greater risk in trading these events which may not react as they would under normal market conditions. Please take extra caution before tradin
Links To Latest News and Headlines
Zacks.com users have recently been watching DocuSign (DOCU) quite a bit. Thus, it is worth knowing the facts that could determine the stock’s prospects.
Stanley Druckenmiller’s Duquesne Capital Management fund delivered 30% annual returns for decades before he converted it to a smaller family office. During the first quarter, the Duquesne Family Office added heavily to positions in Taiwan Semiconductor and Flutter Entertainment. Druckenmiller began a new position in Docusign during the first three months of 2025.
In the closing of the recent trading day, DocuSign (DOCU) stood at $89.83, denoting a -1.62% change from the preceding trading day.
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other business lines such as M&A advisory.
Docusign (Nasdaq: DOCU) today announced that its first quarter fiscal 2026 results will be released on Thursday, June 5, 2025, after the close of the market. The company will host a conference call at 2:00 p.m. Pacific Standard Time (5:00 p.m. Eastern Standard Time) to discuss its financial results. A live webcast of the event will be available on the Docusign Investor Relations website at investor.docusign.com. A live dial-in will be available domestically at 877-407-0784 or internationally at
StockJumpers analysis and trade plans are finalized and uploaded generally one house before market cloase (3PM EST) for most events unless noticed.
“I’m sorry, this content is for members only. To access this content, you must log in with your membership credentials – OR if you are not a member yet, visit our registration page here and get signed up Looking forward to having you on-board ASAP”
There is a significant amount of data behind the scenes involved in the analysis and trade plan tab above, that does not get put into the report. Too much information for traders often confuses things – so this is stripped down to only what is needed to make the best possible decision(s) on trading the trajectory.
Avg Daily Volume: 4,886,514 Market Cap: 39.36B
Sector: Technology Short Interest: None
Ticker delayed 20 minutes
NOTICE: All material on this site has been published for informational and educational purposes only and does not constitute an offer to sell nor a solicitation of an offer to buy any security which may be referenced here or in our websites. StockJumpers is not an Investment Adviser and relies on the publisher’s exemption as defined in Section 401(f) of the Uniform Securities Act, and provides no personal advice or recommendations. The services and published information contained herein is for non-commercial, educational use and display. StockJumpers and any of its affiliates does not represent that the securities or services discussed are suitable for any investor. You should assume that StockJumpers and or its management has or will take a position in the stock, whether it is stated or not. You are further advised not to rely on any information contained in this report and associated websites in the process of making a fully informed investment decision. Trading is risky and you can lose your investment. For the complete risk disclosure and other legal information please review the full Terms of Use Agreement.